What is doxepin?

Medical Advisory BoardAll articles are reviewed for accuracy by our Medical Advisory Board
Educational purpose only • Exercise caution as content is pending human review
Article Review Status
Submitted
Under Review
Approved

Last updated: September 23, 2025View editorial policy

Personalize

Help us tailor your experience

Which best describes you? Your choice helps us use language that's most understandable for you.

Doxepin: A Medication for Insomnia and Depression

Doxepin is a tricyclic compound that functions primarily as a histamine H1 receptor antagonist at low doses (3-6 mg) for treating insomnia, and as an antidepressant at higher doses (10-150 mg) for treating depression, anxiety, and related conditions. 1

Low-Dose Doxepin for Insomnia

Mechanism of Action

  • At low doses (1-6 mg), doxepin acts as a highly selective histamine H1 receptor antagonist, which promotes sleep initiation and maintenance 2
  • This selective H1 antagonism differentiates low-dose doxepin from its action at higher antidepressant doses

Efficacy for Insomnia

  • Particularly effective for sleep maintenance insomnia rather than sleep initiation problems 3
  • Clinical trials demonstrate significant improvements in:
    • Wake time after sleep onset (WASO): Mean reduction of 22-23 minutes compared to placebo 4
    • Total sleep time (TST): Mean improvement of 26-32 minutes compared to placebo 4
    • Sleep efficiency: Clinically significant improvements at both 3 mg and 6 mg doses 4
    • Sleep quality: Small-to-moderate improvement compared to placebo 4

Dosing for Insomnia

  • Recommended doses: 3 mg or 6 mg taken once daily before bedtime 4
  • Clinical guidelines recommend:
    • Starting with 3 mg for most adults
    • 6 mg may be more effective but with slightly increased risk of somnolence 4
    • Effects are evident after a single administration and can be maintained for up to 12 weeks 2

Safety Profile for Low-Dose Use

  • Generally well-tolerated with minimal side effects at low doses 2
  • Most common side effects include mild somnolence and headache, often at placebo level 5
  • No evidence of:
    • Tolerance development
    • Physical dependence
    • Rebound insomnia upon discontinuation
    • Significant next-day residual effects 2, 5

Higher-Dose Doxepin for Depression and Anxiety

Indications

  • FDA-approved for:
    1. Psychoneurotic patients with depression and/or anxiety
    2. Depression and/or anxiety associated with alcoholism
    3. Depression and/or anxiety associated with organic disease
    4. Psychotic depressive disorders with associated anxiety 1

Mechanism at Higher Doses

  • At antidepressant doses (10-150 mg), doxepin affects multiple neurotransmitter systems:
    • Prevents reuptake of norepinephrine at nerve terminals
    • Has anticholinergic, antiserotonin, and antihistamine effects 1

Dosing for Depression/Anxiety

  • Typical therapeutic range: 10-150 mg daily 1
  • At doses above 150 mg/day, may block antihypertensive effects of certain medications 1

Safety Considerations for Higher Doses

  • Black box warning: Increased risk of suicidal thinking and behavior in children, adolescents, and young adults 1
  • Common side effects at higher doses:
    • Dry mouth
    • Drowsiness
    • Constipation
    • Anticholinergic effects 6
  • Not recommended for use in children under 12 years 1

Clinical Decision-Making Algorithm

  1. For insomnia (particularly sleep maintenance):

    • First-line: Non-pharmacological approaches (CBT-I or BBT-I) 4
    • If non-pharmacological approaches fail or are unavailable:
      • Consider low-dose doxepin (3-6 mg) for short-term use
      • Start with 3 mg; increase to 6 mg if needed and tolerated
      • Monitor for effectiveness and side effects
  2. For depression and/or anxiety:

    • Consider standard antidepressant doses (10-150 mg)
    • Start at lower doses and titrate based on response
    • Monitor closely for side effects and suicidality, especially in younger patients

Important Caveats and Precautions

  • Contraindicated in individuals with hypersensitivity to the drug 1
  • Use with caution in patients with:
    • Cardiovascular disease (though better tolerated than some other tricyclics) 6
    • Glaucoma or urinary retention (due to anticholinergic effects at higher doses)
  • Not approved for pediatric use 1
  • Patients started on antidepressant doses should be monitored for clinical worsening, suicidality, or unusual changes in behavior 1

Low-dose doxepin represents a different approach to insomnia treatment compared to traditional hypnotics, with its selective histamine antagonism providing benefits for sleep maintenance with minimal side effects when used appropriately.

Professional Medical Disclaimer

This information is intended for healthcare professionals. Any medical decision-making should rely on clinical judgment and independently verified information. The content provided herein does not replace professional discretion and should be considered supplementary to established clinical guidelines. Healthcare providers should verify all information against primary literature and current practice standards before application in patient care. Dr.Oracle assumes no liability for clinical decisions based on this content.

Have a follow-up question?

Our Medical A.I. is used by practicing medical doctors at top research institutions around the world. Ask any follow up question and get world-class guideline-backed answers instantly.